Keyphrases
CGS21680
100%
Adenosine A2A Receptor (A2AR)
100%
Nonalcoholic Steatohepatitis
100%
Lipotoxicity
66%
Interleukin-17 (IL-17)
50%
Methionine
33%
Receptor Agonist
33%
Interleukin-12 (IL-12)
33%
Phosphoinositide 3-kinase (PI3K)
33%
Tumor Necrosis Factor-α
33%
Chemokine (C-C motif) Ligand 2 (CCL2)
33%
T Helper 17 (Th17)
33%
CD4+ T
33%
Helper Cells
33%
Mouse Hepatocytes
33%
CXCL10
33%
Steatotic
33%
Palmitic Acid
33%
Immuno-inflammatory Response
33%
Tumor Growth Factor
33%
Potential Clinical Applications
16%
C57BL
16%
Liver
16%
Receptor Activation
16%
Chemokines
16%
Regulatory T (Treg) Cells
16%
T Helper Cells
16%
Akt Phosphorylation
16%
Acid Treatment
16%
Steatosis
16%
Potentiation
16%
Immunosuppressive Agents
16%
Immunosuppressive Activity
16%
Immuno
16%
Cell Polarization
16%
PTEN Expression
16%
Cell Infiltration
16%
Th1 Cells
16%
Negative Regulator
16%
Phosphatase and Tensin Homolog Deleted from Chromosome 10
16%
Interleukin-22 (IL-22)
16%
Th22 Cells
16%
Cell Recruitment
16%
Cell Expansion
16%
Multi-face
16%
JNK Activation
16%
Cytoprotective Agents
16%
Pharmacology, Toxicology and Pharmaceutical Science
2 [4 (2 Carboxyethyl)phenethylamino]adenosine 5' (N Ethylcarboxamide)
100%
Nonalcoholic Fatty Liver
100%
Adenosine A2a Receptor
100%
Lipotoxicity
66%
Interleukin 17
50%
Tumor Necrosis Factor
33%
Receptor Agonist
33%
Phosphatidylinositol 3 Kinase
33%
Methionine
33%
Palmitic Acid
33%
Cancer Growth Factor
33%
Receptor
16%
Cytoprotective Agent
16%
Immunosuppressive Agent
16%
Cytokine
16%
Immunoglobulin
16%
Chemokine
16%
Steatosis
16%
Tensin
16%
C57BL 6 Mouse
16%
Phosphatase
16%
Immunology and Microbiology
Steatohepatitis
100%
T Helper Cell
50%
Interleukin 17
50%
Agonist
33%
CD4
33%
Tumor Necrosis Factor Alpha
33%
CCL2
33%
Th17 Cell
33%
CXCL10
33%
Cancer Growth Factor
33%
C57BL 6 Mouse
16%
Chemokine
16%
Cytokine
16%
Immunosuppressive Drug
16%
Regulatory T Cell
16%
Intravenous Immunoglobulin
16%
Cell Expansion
16%
Th1 Cell
16%
Th22 Cell
16%
Chromosome 10
16%
Cell Infiltration
16%